Loading clinical trials...
Loading clinical trials...
The English Version of the Drug Hypersensitivity Quality of Life Questionnaire: Validity and Reliability in the British Population.
We aim to validate the English (UK) translation of the DrHy-Q, and test its reliability in the UK population. This will facilitate for the subsequent economical evaluation of penicillin allergy delabelling. This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London. Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic. Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
UNiversity Hospitals Leicester
Leicester, United Kingdom
Start Date
March 21, 2023
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2024
Last Updated
July 26, 2024
146
ACTUAL participants
Questionnaires
OTHER
Lead Sponsor
University Hospitals, Leicester
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions